1.
Barillari P, Aurello P, De Angelis R, Valabrega S, Ramacciato G, D'Angelo F & Fegiz
G. Management and survival of patients affected with obstructive colorectal cancer.
Int Surg. 77(4):251-255:1992.
2.
Dohmoto M. New method: Endoscopic implantation of rectal stent in palliative
treatment of malignant stenosis. Endoscopy Digest. 3:1507-1512:1991.
3.
van Hooft J E, van Halsema E E, Vanbiervliet G, Beets-Tan R G, DeWitt J M,
Donnellan F, Dumonceau J M, Glynne-Jones R G, Hassan C, Jimenez-Perez J,
Meisner S, Muthusamy V R, Parker M C, Regimbeau J M, Sabbagh C, Sagar J, Tanis
P J, Vandervoort J, Webster G J, Manes G, Barthet M A, Repici A. Self-expandable
metal stents for obstructing colonic and extracolonic cancer: European Society of
Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Gastrointest Endosc. 80:747761 e741-775:2014.
4.
Tung K L, Cheung H Y, Ng L W, Chung C C, Li M K. Endo-laparoscopic approach
versus conventional open surgery in the treatment of obstructing left-sided colon
cancer: long-term follow-up of a randomized trial. Asian J Endosc Surg. 6(2):7881:2013.
5.
Alcántara M, Serra-Aracil X, Falcó J, Mora L, Bombardó J, Navarro S. Prospective,
controlled, randomized study of intraoperative colonic lavage versus stent placement
in obstructive left-sided colonic cancer. World J Surg. 35(8):1904-1910:2011.
71
6.
van Hooft J E, van Halsema E E, Vanbiervliet G, Beets-Tan R G, DeWitt J M ,
Donnellan F, Dumonceau J M, Glynne-Jones R G, Hassan C, Jiménez-Perez J,
Meisner S, Muthusamy V R, Parker M C, Regimbeau J M, Sabbagh C, Sagar J, Tanis
P J , Vandervoort J, Webster G J, Manes G, Barthet M A & Repici A. Self-expandable
metal stents for obstructing colonic and extracolonic cancer: European Society of
Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 46(11):9901053:2014.
7.
Cheung D Y, Kim J Y, Hong S P, Jung M K, Ye B D, Kim S G, Kim J H , Lee K M,
Kim K H, Baik G H, Kim H G, Eun C S, Kim T I, Kim S W, Kim C D & Yang C H.
Outcome and safety of self-expandable metallic stents for malignant colon
obstruction: a Korean multicenter randomized prospective study. Surg Endosc.
26(11):3106-3113:2012.
8.
Saito S, Yoshida S, Isayama H, Matsuzawa T, Kuwai T, Maetani I, Shimada M,
Yamada T, Tomita M, Koizumi K, Hirata N, Kanazawa H, Enomoto T, Sekido H. &
Saida Y. A prospective multicenter study on self-expandable metallic stents as a
bridge to surgery for malignant colorectal obstruction in Japan: efficacy and safety in
312 patients. Surg Endosc.30(9):3976-3986:2016.
9.
Allievi N, Ceresoli M, Fugazzola P, Montori G, Coccolini F and Ansaloni L.
Endoscopic Stenting as Bridge to Surgery versus Emergency Resection for Left72
Sided Malignant Colorectal Obstruction: An Updated Meta-Analysis. Int J Surg
Oncol. 2017: 2863272:2017.
10.
Amelung F J, Burghgraef T A, Tanis P J, van Hooft J E, Ter Borg F, Siersema P D,
Bemelman W A and Consten E C J. Critical appraisal of oncological safety of stent
as bridge to surgery in left-sided obstructing colon cancer: a systematic review and
meta-analysis. Crit Rev Oncol Hematol.131:66-75:2018.
11.
Foo C C, Poon S H T, Chiu R H Y, Lam W Y, Cheung L C and Law W L. Is bridge to
surgery stenting a safe alternative to emergency surgery in malignant colonic
obstruction: a meta-analysis of randomized control trials. Surg Endosc. 33: 293302:2019.
12.
Matsuda A, Miyashita M, Matsumoto S, Matsutani T, Sakurazawa N, Takahashi G,
Kishi T and Uchida E. Comparison of long-term outcomes of colonic stent as "bridge
to surgery" and emergency surgery for malignant large-bowel obstruction: a metaanalysis. Ann Surg Oncol. 22: 497-504:2015.
13.
Wang X, He J, Chen X and Yang Q. Stenting as a bridge to resection versus
emergency surgery for left-sided colorectal cancer with malignant obstruction: A
systematic review and meta-analysis. Int J Surg. 48: 64-68:2017.
73
14.
Yang P, Lin X F, Lin K and Li W. The Role of Stents as Bridge to Surgery for Acute
Left-Sided Obstructive Colorectal Cancer: Meta-Analysis of Randomized Controlled
Trials. Rev Invest Clin .70: 269-278:2018.
15.
Zhao X, Liu B, Zhao E, Wang J, Cai M, Xia Z, Xia Q, Shuai X, Tao K, Wang G and
Cai K. The safety and efficiency of surgery with colonic stents in left-sided
malignant colonic obstruction: a meta-analysis. Gastroenterol Res Pract. 2014:
407325:2014.
16.
van Hooft J E, Veld J V, Arnold D, Beets-Tan R G H, Everett S, Götz M, van
Halsema E E, Hill J, Manes G, Meisner S, Rodrigues-Pinto E, Sabbagh C,
Vandervoort J, Tanis P J, Vanbiervliet G & Arezzo A. Self-expandable metal stents
for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal
Endoscopy (ESGE) Guideline - Update 2020. Endoscopy. 52(5):389-407:2020.
17.
Pagès F, Mlecnik B, Marliot F, Bindea G, Ou F S, Bifulco C, Lugli A, Zlobec I, Rau T
T, Berger M D, Nagtegaal I D, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J,
Merkel S, Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard
D, Remue C, Wang J Y, Bavi P, Roehrl M H A, Ohashi P S, Nguyen L T, Han S,
MacGregor H L, Hafezi-Bakhtiari S, Wouters B G, Masucci G V, Andersson E K,
Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H,
Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi
74
F , Fredriksen T, Buttard B, Angelova M, Vasaturo A, Maby P, Church S E, Angell H
K, Lafontaine L, Bruni D, El Sissy C, Haicheur N, Kirilovsky A, Berger A, Lagorce
C, Meyers J P, Paustian C, Feng Z, Ballesteros-Merino C, Dijkstra J, van de Water C,
van Lent-van Vliet S, Knijn N, Mușină A M, Scripcariu D V, Popivanova B, Xu M,
Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T,
Takemasa I, Itoh K, Patel P S, Vora H H, Shah B, Patel J B, Rajvik K N, Pandya S J,
Shukla S N, Wang Y, Zhang G, Kawakami Y, Marincola F M, Ascierto P A, Sargent
D J, Fox B A & Galon J. International validation of the consensus Immunoscore for
the classification of colon cancer: a prognostic and accuracy study. Lancet.
391(10135):2128-2139:2018.
18.
Galon J, Mlecnik B, Bindea G, Angell H K, Berger A, Lagorce C, Lugli A, Zlobec I,
Hartmann A, Bifulco C, Nagtegaal I D, Palmqvist R, Masucci G V, Botti G, Tatangelo
F, Delrio P, Maio M, Laghi L, Grizzi F, Asslaber M, D'Arrigo C, Vidal-Vanaclocha F,
Zavadova E, Chouchane L, Ohashi P S, Hafezi-Bakhtiari S, Wouters B G, Roehrl M,
Nguyen L, Kawakami Y, Hazama S, Okuno K, Ogino S, Gibbs P, Waring P, Sato N,
Torigoe T, Itoh K, Patel P S , Shukla S N, Wang Y, Kopetz S, Sinicrope F A,
Scripcariu V, Ascierto P A, Marincola F M, Fox B A & Pagès F. Towards the
introduction of the 'Immunoscore' in the classification of malignant tumours. J Pathol.
232(2):199-209:2014.
75
19.
Ascierto P A, Marincola F M, Fox B A and Galon J. No time to die: the consensus
immunoscore for predicting survival and response to chemotherapy of locally
advanced colon cancer patients in a multicenter international study. Oncoimmunology.
9:1826132:2020.
20.
Teng M W, Ngiow S F, Ribas A. and Smyth M J. Classifying Cancers Based on T-cell
Infiltration and PD-L1. Cancer Res.75: 2139-2145:2015.
21.
Gajewski T F, Schreiber H and Fu Y X. Innate and adaptive immune cells in the.
tumor microenvironment. Nat Immunol.14:1014-1022:2013.
22.
Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Kawano Y, Yamahatsu K,
Sekiguchi K, Yamada M, Hatori T & Yoshida H. Colonic stent-induced mechanical
compression may suppress cancer cell proliferation in malignant large bowel
obstruction. Surg Endosc. 33(4):1290-1297:2019.
23.
Fryer E, Gorissen KJ, Wang LM, Guy R, Chetty R. Spectrum of histopathological
changes encountered in stented colorectal carcinomas. Histopathology. 66(4):480484:2015.
24.
Amini N, Haydel D, Reisian N, Sempa G, Chu J, Wang Q, Zhao G, Stamos M J and
Wu M L. Colorectal stents orient specimens and induce artifacts that mimic Crohn
disease. Int J Surg Pathol. 20:161-168:2012.
76
25.
Buechter KJ, Boustany C, Caillouette R, Cohn I Jr. Surgical management of the
acutely obstructed colon. A review of 127 cases. Am J Surg. 156(3 Pt 1):163168:1988.
26.
Fiori E, Lamazza A, De Cesare A, Bononi M, Volpino P, Schillaci A, Cavallaro A,
Cangemi V. Palliative management of malignant rectosigmoidal obstruction.
Colostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res.
24:265-268:2004.
27.
Sebastian S, Johnston S, Geoghegan T, Torreggiani W, Buckley M. Pooled analysis of
the efficacy and safety of self-expanding metal stenting in malignant colorectal
obstruction. Am J Gastroenterol. 99:2051-2057:2004.
28.
Tilney H S, Lovegrove R E, Purkayastha S, Sains P S, Weston-Petrides G K, Darzi A
W, Tekkis P P, Heriot A G. Comparison of colonic stenting and open surgery for
malignant large bowel obstruction. Surg Endosc. 21:225-233:2007.
29.
Ragland J J, Londe A M and Spratt J S Jr. Correlation of the prognosis of obstructing
colorectal carcinoma with clinical and pathologic variables: Am J Surg.121:552556:1971.
30.
Galon J and Lanzi A. Immunoscore and its introduction in clinical practice. Q J Nucl
Med Mol Imaging.64:152-161.2020.
77
31.
Mlecnik B, Bifulco C, Bindea G, Marliot F, Lugli A, Lee J J, Zlobec I, Rau T T,
Berger M D, Nagtegaal I D, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J,
Merkel S, Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard
D, Remue C, Wang J Y, Bavi P, Roehrl M H A, Ohashi P S, Nguyen L T, Han S,
MacGregor H L, Hafezi-Bakhtiari S, Wouters B G, Masucci G V, Andersson E K,
Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H,
Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi F,
Fredriksen T, Buttard B, Lafontaine L, Bruni D, Lanzi A, El Sissy C, Haicheur N,
Kirilovsky A, Berger A, Lagorce C, Paustian C, Ballesteros-Merino C, Dijkstra J, van
de Water C, van Lent-van Vliet S, Knijn N, Muşină A M, Scripcariu D V, Popivanova
B, Xu M, Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N,
Furuhata T, Takemasa I, Itoh K, Patel P S, Vora H H, Shah B, Patel J B, Rajvik K N,
Pandya S J, Shukla S N, Wang Y, Zhang G, Kawakami Y, Marincola F M, Ascierto P
A, Fox B A, Pagès F and Galon J. Multicenter International Society for
Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of
Survival and Response to Chemotherapy in Stage III Colon Cancer. J Clin Oncol. 38:
3638-3651:2020.
32.
Pagès F, André T, Taieb J, Vernerey D, Henriques J. Borg C, Marliot F, Ben Jannet R,
Louvet C, Mineur L, Bennouna J, Desrame J, Faroux R, Kirilovsky A, Duval A,
78
Laurent-Puig P, Svrcek M, Hermitte F, Catteau A, Galon J and Emile J F. Prognostic
and predictive value of the Immunoscore in stage III colon cancer patients treated with
oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study. Ann
Oncol. 31:921-929:2020.
33.
Marliot F, Chen X, Kirilovsky A, Sbarrato T, El Sissy C, Batista L, Van den Eynde M,
Haicheur-Adjouri N, Anitei M G, Musina A M, Scripcariu V, Lagorce-Pagès C,
Hermitte F, Galon J, Fieschi J and Pagès F. Analytical validation of the Immunoscore
and its associated prognostic value in patients with colon cancer. J Immunother
Cancer. 8:e000272:2020.
34.
Sinicrope F A, Shi Q, Hermitte F, Zemla T J, Mlecnik B, Benson A B, Gill S, Goldberg
R M, Kahlenberg M S, Nair S G, Shields A F, Smyrk T C, Galon J and Alberts S R.
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage
III Colon Cancer. JNCI Cancer Spectr. 4:pkaa023:2020.
35.
Mlecnik B, Bindea G, Kirilovsky A, Angell H K, Obenauf A C, Tosolini M, Church S
E, Maby P, Vasaturo A, Angelova M, Fredriksen T, Mauger S, Waldner M, Berger A,
Speicher M R, Pagès F, Valge-Archer V and Galon J. The tumor microenvironment
and Immunoscore are critical determinants of dissemination to distant metastasis. Sci
Transl Med.8:327ra326:2016.
79
36.
Mlecnik B, Bindea G, Angell H K, Maby P, Angelova M, Tougeron D, Church S E,
Lafontaine L, Fischer M, Fredriksen T, Sasso M, Bilocq A M, Kirilovsky A, Obenauf
A C, Hamieh M, Berger A, Bruneval P, Tuech J J, Sabourin J C, Le Pessot F, Mauillon
J, Rafii A, Laurent-Puig P, Speicher M R, Trajanoski Z, Michel P, Sesboüe R,
Frebourg T, Pagès F, Valge-Archer V, Latouche J B and Galon J. Integrative Analyses
of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival
Than Microsatellite Instability. Immunity. 44:698-711:2016.
37.
Mlecnik B, Van den Eynde M, Bindea G, Church S E, Vasaturo A, Fredriksen T,
Lafontaine L, Haicheur N, Marliot F, Debetancourt D, Pairet G, Jouret-Mourin A,
Gigot J F, Hubert C, Danse E, Dragean C, Carrasco J, Humblet Y, Valge-Archer V,
Berger A, Pagès F, Machiels J P and Galon J. Comprehensive Intrametastatic Immune
Quantification and Major Impact of Immunoscore on Survival. J Natl Cancer Inst.
110:97-108:2018.
38.
Yomoda T, Sudo T, Kawahara A, Shigaki T, Shimomura S, Tajiri K, Nagasu S, Fujita
F, Kinugasa T and Akagi Y. The Immunoscore is a Superior Prognostic Tool in Stages
II and III Colorectal Cancer and is Significantly Correlated with Programmed DeathLigand 1 (PD-L1) Expression on Tumor-Infiltrating Mononuclear Cells. Ann Surg
Oncol. 26(2):415-424:2019.
80
39.
Kirilovsky A, Marliot F, El Sissy C, Haicheur N, Galon J and Pagès F. Rational bases
for the use of the Immunoscore in routine clinical settings as a prognostic and
predictive biomarker in cancer patients. Int Immunol. 28(8):373-382:2016.
40.
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C,
Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc P H,
Trajanoski Z, Fridman W H & Pagès F. Type, density, and location of immune cells
within human colorectal tumors predict clinical outcome. Science. 313(5795):19601964:2006.
41.
Fridman WH, Pagès F, Sautès-Fridman C and Galon J. The immune contexture in
human tumours: impact on clinical outcome. Nat Rev Cancer. 12(4):298-306:2012.
42.
Sargent D J, Wieand H S, Haller D G, Gray R, Benedetti J K, Buyse M, Labianca R,
Seitz J F, O'Callaghan C J, Francini G, Grothey A, O'Connell M, Catalano P J, Blanke
C D, Kerr D, Green E, Wolmark N, Andre T, Goldberg R M & De Gramont A.
Disease-free survival versus overall survival as a primary end point for adjuvant colon
cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J
Clin Oncol. 23(34):8664-8670:2005.
43.
Pagès F, André T, Taieb J, Vernerey D, Henriques J, Borg C, Marliot F, Ben Jannet R,
Louvet C, Mineur L, Bennouna J, Desrame J, Faroux R, Kirilovsky A, Duval A,
Laurent-Puig P, Svrcek M, Hermitte F, Catteau A, Galon J and Emile J F. Prognostic
81
and predictive value of the Immunoscore in stage III colon cancer patients treated with
oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study. Ann
Oncol.31(7):921-929:2020.
44.
Frago R, Ramirez E, Millan M, Kreisler E, del Valle E, Biondo S. Current
management of acute malignant large bowel obstruction: a systematic review. Am J
Surg. 207:127-138:2014.
45.
Cetinkaya E, Dogrul A B, Tirnaksiz M B. Role of self expandable stents in
management of colorectal cancers. World J Gastrointest Oncol. 8:113-120:2016.
46.
Arezzo A, Balague C, Targarona E, Borghi F, Giraudo G, Ghezzo L, Arroyo A, SolaVera J, De Paolis P, Bossotti M, Bannone E, Forcignano E, Bonino M A, Passera R,
Morino M. Colonic stenting as a bridge to surgery versus emergency surgery for
malignant colonic obstruction: results of a multicentre randomised controlled trial
(ESCO trial). Surg Endosc. 31:3297-3305:2017.
47.
Cheung H Y, Chung C C, Tsang W W, Wong J C, Yau K K and Li M K.
Endolaparoscopic approach vs conventional open surgery in the treatment of
obstructing left-sided colon cancer: a randomized controlled trial. Arch Surg. 144:
1127-1132:2009.
82
48.
Huang X, Lv B, Zhang S, Meng L. Preoperative colonic stents versus emergency
surgery for acute left-sided malignant colonic obstruction: a meta-analysis. J
Gastrointest Surg. 18(3):584-591:2014.
49.
Tomita M, Saito S, Makimoto S, Yoshida S, Isayama H, Yamada T, Matsuzawa T,
Enomoto T, Kyo R, Kuwai T, Hirata N, Shimada M, Hirakawa T, Koizumi K and
Saida Y. Self-expandable metallic stenting as a bridge to surgery for malignant
colorectal obstruction: pooled analysis of 426 patients from two prospective
multicenter series. Surg Endosc. 33(2):499-509:2019.
50.
Ceresoli M, Allievi N, Coccolini F, Montori G, Fugazzola P, Pisano M, Sartelli M,
Catena F, Ansaloni L. Long-term oncologic outcomes of stent as a bridge to surgery
versus emergency surgery in malignant left side colonic obstructions: a meta-analysis.
J Gastrointest Oncol. 8:867-876:2017.
51.
Yan F H, Lou Z, Liu X S, Wang Z, Xu X D, Gao Y J, He J, Wang H, Fu C G, Zhang
W, He H Y, Cai B L, Yu E D. Long-Term Oncological Outcomes of Endoscopic
Stenting as a Bridge to Surgery Versus Emergency Surgery for Malignant Colorectal
Obstruction: A Comparative Study. J Laparoendosc Adv Surg Tech A. 27:611617:2017.
52.
Sabbagh C, Browet F, Diouf M, Cosse C, Brehant O, Bartoli E, Mauvais F, Chauffert
B, Dupas J L, Nguyen-Khac E, Regimbeau J M. Is stenting as "a bridge to surgery" an
83
oncologically safe strategy for the management of acute, left-sided, malignant, colonic
obstruction? A comparative study with a propensity score analysis. Ann Surg.
258:107-115:2013.
53.
Sloothaak D A, van den Berg M W, Dijkgraaf M G, Fockens P, Tanis P J, van Hooft J
E, Bemelman W A . Oncological outcome of malignant colonic obstruction in the
Dutch Stent-In 2 trial. Br J Surg. 101:1751-1757:2014.
54.
Cancer J S f C o t C. JSCCR Guidelines 2016 for the Treatment of Colorectal Cancer.
2016.
55.
Kim S J, Kim H W, Park S B, Kang D H, Choi C W, Song B J, Hong J B, Kim D J,
Park B S and Son G M. Colonic perforation either during or after stent insertion as a
bridge to surgery for malignant colorectal obstruction increases the risk of peritoneal
seeding. Surg Endosc. 29:3499-3506:2015.
84
...
論文の公開元へ
